RecruitingNot ApplicableNCT06435533

Cold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous Polyposis


Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrollment

10 participants

Start Date

Dec 6, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to investigate the feasibility for the treatment of precancerous peri-ampullary FAP polyps in the duodenum using low-thermal argonplasma.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether cold atmospheric plasma — a type of ionized gas delivered through an endoscope — can treat small polyps in the small intestine (duodenum) in patients with Familial Adenomatous Polyposis (FAP), a genetic condition that causes many polyps to grow in the digestive tract. **You may be eligible if...** - You have a confirmed diagnosis of FAP - You have duodenal polyps that have been classified as Spigelman stage III (a moderate level of polyp burden) - Your polyps are smaller than 10 mm - You are able and willing to provide written informed consent **You may NOT be eligible if...** - Your polyps appear suspicious for high-grade cell changes or cancer - You are pregnant or breastfeeding - You have serious medical illnesses with a life expectancy under 1 year - You have a severe blood clotting disorder - Your intestine has inflammation, scarring, or narrowing that prevents the procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICElow energy argonplasma coagulation

see above


Locations(1)

University Hospital Hamburg-Eppendorf

Hamburg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06435533


Related Trials